Investing.com
Earnings call: Aurinia Pharmaceuticals reports a YoY revenue growth of 46% By Investing.com
7 hours ago
Aurinia shares price target cut, hold rating maintained on consistent revenues By Investing.com
8 hours ago
Houston Chronicle
Aurinia: Q1 Earnings Snapshot
EDMONTON, Alberta (AP) — Aurinia Pharmaceuticals Inc. (AUPH) on Thursday reported a loss of $10.7 million in its first quarter. On a per-share basis, the Edmonton, Alberta-based company said ...
19 hours ago
Morningstar
Aurinia Underscores Enduring Commitment to People Living with Lupus Nephritis Through Innovative Advocacy and Education Initiatives for Lupus Awareness...
In recognition of Lupus Awareness Month, Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company), today announced several initiatives to improve understanding of the seriousness ...
2 days ago
Knox Daily
Oppenheimer downgrades Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc’s recently made public that its Chief Executive Officer Greenleaf Peter unloaded Company’s shares for reported $0.71 million on Mar 06 ’24. In the deal valued at ...
Chief Executive Officer Greenleaf Peter sale 126,981 shares of Aurinia Pharmaceuticals Inc [AUPH] – Knox Daily
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Aurinia Pharmaceuticals Inc shares valued at $711,094 were sold ...
7 days ago
auriniapharma.com
More on Yahoo Finance